Plaquenil is used to treat or prevent malaria, a disease caused by parasites that enter the body through the bite of a mosquito. Malaria is common in areas such as Africa, South America, and Southern Asia. What is plaquenil use for Cost of plaquenil in australia Hydroxychloroquine Plaquenil is a drug that is classified as an anti-malarial drug. Plaquenil is prescribed for the treatment or prevention of malaria. It is also prescribed for the treatment of rheumatoid arthritis, lupus, and the side effects of lupus such as hair loss, joint pain, and more. This page answers frequently asked questions FAQ about drug shortages such as what is a drug shortage, how many per year, how the FDA addresses and takes action on shortages, how the FDA. Search by Generic Name or Active Ingredient Current/Resolved Shortages; Discontinuations; Therapeutic Categories; New and Updated. A drug receives. Plaquenil is also an antirheumatic medicine and is used to treat symptoms of rheumatoid arthritis and discoid or systemic lupus erythematosus. This medicine is not effective against all strains of malaria. Plaquenil generic shortage Plaquenil Shortage Leaves RA, Lupus Patients in Pain and., Frequently Asked Questions about Drug Shortages FDA Plaquenil sjogren disease doesnt work 2019Can you take plaquenil with lipitorChloroquine phosphate brand name Drug Shortages can occur for many reasons, including manufacturing and quality problems, delays, and discontinuations. Manufacturers provide FDA most drug shortage information, and the agency. Drug Shortages FDA. FDA Drug Shortages. Plaquenil shortage. -. Our Plaquenil hydroxychloroquine Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication. This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. In April 2015, Concordia acquired Plaquenil from Covis this is the manufacturer of the Plaquenil tablets I have been taking and have no issues with. The ASHP American Society of Health-System Pharmacists reported a shortage of certain generics manufactured by Ranbaxy and Sandoz. No shortage in the U. S. for the name brand or other generics. Discontinuations Listed by Generic Name or Active Ingredient Companies are required under Section 506C of the Federal Food, Drug, and Cosmetic Act FD&C Act as amended by the Food and Drug Administration Safety and Innovation Act to notify FDA of a permanent discontinuance of certain drug products, six months in advance, or if that is not possible, as soon as practicable.